PGS:Gelatin nanofibrous scaffolds with tunable mechanical and structural properties for engineering cardiac tissues

Biomaterials

Volumn 34, Issue 27, 2013, Pages 6355-6366

  Kharaziha, Mahshid ^a,b,c   Nikkhah, Mehdi ^a,b   Shin, Su Ryon ^a,b,d   Annabi, Nasim ^a,b,d   Masoumi, Nafiseh ^a,b   Gaharwar, Akhilesh K ^a,b,d   Camci Unal, Gulden ^a,b   Khademhosseini, Ali ^a,b,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c ISFAHAN UNIVERSITY OF TECHNOLOGY   (Iran)

^d HARVARD UNIVERSITY   (United States)

Author keywords

Cardiac cells; Nanofibrous; Poly(glycerol sebacate):gelatin; Scaffold; Tissue engineering

Indexed keywords

CARDIAC CELL; CARDIAC TISSUE ENGINEERING; CHEMICAL COMPOSITIONS; EXTRACELLULAR MATRICES; LEFT VENTRICULAR MYOCARDIUMS; NANO-FIBROUS; POLIES (GLYCEROLSEBACATE); POLY(GLYCEROL SEBACATE);

ALIGNMENT; ANISOTROPY; BIOMIMETICS; CELL CULTURE; CELLS; GLYCEROL; HEART; NANOFIBERS; REPAIR; SCAFFOLDS; STRUCTURAL PROPERTIES; TISSUE; TISSUE ENGINEERING;

SCAFFOLDS (BIOLOGY);

ELASTOMER; GELATIN; MOLECULAR SCAFFOLD; POLY(GLYCEROL SEBACATE); SEBACIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANISOTROPY; ARTICLE; BIODEGRADABILITY; BIOMIMETICS; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; CHEMICAL COMPOSITION; CHEMICAL STRUCTURE; CONTROLLED STUDY; ELECTROSPINNING; EXTRACELLULAR MATRIX; FIBROBLAST; HEART LEFT VENTRICLE; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; MECHANICS; NEWBORN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RIGIDITY; TISSUE ENGINEERING; TISSUE REGENERATION; TISSUE REPAIR;

ANIMALS; CELL ADHESION; CELL PROLIFERATION; CELLS, CULTURED; DECANOATES; FIBROBLASTS; GELATIN; GLYCEROL; MYOCARDIUM; MYOCYTES, CARDIAC; NANOFIBERS; POLYMERS; RATS; RATS, SPRAGUE-DAWLEY; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

RATTUS;

EID: 84879080205     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.04.045     Document Type: Article

References (62)

1. Tandon V., Zhang B., Radisic M., Murthy S.K. Generation of tissue constructs for cardiovascular regenerative medicine: from cell procurement to scaffold design. Biotechnol Adv 2012 Aug 24, pii: S0734-9750(12)00145-0. http://dx.doi.org/10.1016/j.biotechadv.2012.08.006. [Epub ahead of print].
2. Brown R.D., Ambler S.K., Mitchell M.D., Long C.S. The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. Annu Rev Pharmacol Toxicol 2005, 45:657-687.
3. Marsano A., Maidhof R., Wan L.Q., Wang Y., Gao J., Tandon N., et al. Scaffold stiffness affects the contractile function of three-dimensional engineered cardiac constructs. Biotechnol Prog 2010, 26:1382-1390.
4. Engler A.J., Carag-Krieger C., Johnson C.P., Raab M., Tang H.-Y., Speicher D.W., et al. Embryonic cardiomyocytes beat best on a matrix with heart-like elasticity: scar-like rigidity inhibits beating. JCell Sci 2008, 121:3794-3802.
5. Au H.T.H., Cheng I., Chowdhury M.F., Radisic M. Interactive effects of surface topography and pulsatile electrical field stimulation on orientation and elongation of fibroblasts and cardiomyocytes. Biomaterials 2007, 28:4277-4293.
6. Nikkhah M., Edalat F., Manoucheri S., Khademhosseini A. Engineering microscale topographies to control the cell-substrate interface. Biomaterials 2012, 33:5230-5246.
7. Wang P.Y., Yu J., Lin J.-H., Tsai W.-B. Modulation of alignment, elongation and contraction of cardiomyocytes through a combination of nanotopography and rigidity of substrates. Acta Biomater 2011, 7:3285-3293.
8. Camelliti P., Gallagher J.O., Kohl P., McCulloch A.D. Micropatterned cell cultures on elastic membranes as an invitro model of myocardium. Nat Protoc 2006, 1:1379-1391.
9. Kai D., Prabhakaran M.P., Jin G.R., Ramakrishna S. Guided orientation of cardiomyocytes on electrospun aligned nanofibers for cardiac tissue engineering. JBiomed Mater Res B Appl Biomater 2011, 98B:379-386.
10. Rockwood D.N., Akins R.E., Parrag I.C., Woodhouse K.A., Rabolt J.F. Culture on electrospun polyurethane scaffolds decreases atrial natriuretic peptide expression by cardiomyocytes invitro. Biomaterials 2008, 29:4783-4791.
11. Riboldi S.A., Sadr N., Pigini L., Neuenschwander P., Simonet M., Mognol P., et al. Skeletal myogenesis on highly orientated microfibrous polyesterurethane scaffolds. JBiomed Mater Res A 2008, 84A:1094-1101.
12. Carrier R.L., Rupnick M., Langer R., Schoen F.J., Freed L.E., Vunjak-Novakovic G. Perfusion improves tissue architecture of engineered cardiac muscle. Tissue Eng 2002, 8:175-188.
13. Vandenburgh H.H., Solerssi R., Shansky J., Adams J.W., Henderson S.A. Mechanical stimulation of organogenic cardiomyocyte growth invitro. Am J Physiol Cell Physiol 1996, 270:C1284-C1292.
14. Kim H.N., Jiao A., Hwang N.S., Kim M.S., Kang D.H., Kim D.H., et al. Nanotopography-guided tissue engineering and regenerative medicine. Adv Drug Deliv Rev 2012, 65:536-558.
15. Chowdhury F., Na S., Li D., Poh Y.-C., Tanaka T.S., Wang F., et al. Material properties of the cell dictate stress-induced spreading and differentiation in embryonic stem cells. Nat Mater 2010, 9:82-88.
16. Li R.K., Jia Z.Q., Weisel R.D., Mickle D.A.G., Choi A., Yau T.M. Survival and function of bioengineered cardiac grafts. Circulation 1999, 100:63-69.
17. Akhyari P., Fedak P.W.M., Weisel R.D., Lee T.Y.J., Verma S., Mickle D.A.G., et al. Mechanical stretch regimen enhances the formation of bioengineered autologous cardiac muscle grafts. Circulation 2002, 106:I137-I142.
18. Shin M., Ishii O., Sueda T., Vacanti J.P. Contractile cardiac grafts using a novel nanofibrous mesh. Biomaterials 2004, 25:3717-3723.
19. Mukherjee S., Gualandi C., Focarete M.L., Ravichandran R., Venugopal J.R., Raghunath M., et al. Elastomeric electrospun scaffolds of poly(l-lactide-co-trimethylene carbonate) for myocardial tissue engineering. JMater Sci Mater Med 2011, 22:1689-1699.
20. Mukherjee S., Venugopal J.R., Ravichandran R., Ramakrishna S., Raghunath M. Evaluation of the biocompatibility of PLACL/collagen nanostructured matrices with cardiomyocytes as a model for the regeneration of infarcted myocardium. Adv Funct Mater 2011, 21:2291-2300.
21. Chena O., Liang S., Thouas G.A. Elastomeric biomaterials for tissue engineering. Prog Polym Sci 2013, 38:584-671.
22. Wang Y.D., Ameer G.A., Sheppard B.J., Langer R. Atough biodegradable elastomer. Nat Biotechnol 2002, 20:602-606.
23. Sundback C.A., Shyu J.Y., Wang Y.D., Faquin W.C., Langer R.S., Vacanti J.P., et al. Biocompatibility analysis of poly(glycerol sebacate) as a nerve guide material. Biomaterials 2005, 26:5454-5464.
24. Fidkowski C., Kaazempur-Mofrad M.R., Borenstein J., Vacanti J.P., Langer R., Wang Y.D. Endothelialized microvasculature based on a biodegradable elastomer. Tissue Eng 2005, 11:302-309.
25. Engelmayr G.C., Cheng M., Bettinger C.J., Borenstein J.T., Langer R., Freed L.E. Accordion-like honeycombs for tissue engineering of cardiac anisotropy. Nat Mater 2008, 7:1003-1010.
26. Kenar H., Kose G.T., Toner M., Kaplan D.L., Hasirci V. A3D aligned microfibrous myocardial tissue construct cultured under transient perfusion. Biomaterials 2011, 32:5320-5329.
27. Ravichandran R., Venugopal J.R., Sundarrajan S., Mukherjee S., Sridhar R., Ramakrishna S. Minimally invasive injectable short nanofibers of poly(glycerol sebacate) for cardiac tissue engineering. Nanotechnology 2012, 23.
28. Ravichandran R., Venugopal J.R., Sundarrajan S., Mukherjee S., Ramakrishna S. Poly(glycerol sebacate)/gelatin core/shell fibrous structure for regeneration of myocardial infarction. Tissue Eng Part A 2011, 17:1363-1373.
29. Masoumi N., Jean A., Zugates J.T., Johnson K.L., Engelmayr G.C. Laser microfabricated poly(glycerol sebacate) scaffolds for heart valve tissue engineering. JBiomed Mater Res A 2013, 101A:104-114.
30. Shin S.R., Jung S.M., Zalabany M., Kim K., Zorlutuna P., Kim S.B., et al. Carbon-nanotube-embedded hydrogel sheets for engineering cardiac constructs and bioactuators. ACS Nano 2013, 7:2369-2380.
31. Ng C.P., Hinz B., Swartz M.A. Interstitial fluid flow induces myofibroblast differentiation and collagen alignment invitro. JCell Sci 2005, 118:4731-4739.
32. Kim S.B., Bae H., Cha J.M., Moon S.J., Dokmeci M.R., Cropek D.M., et al. Acell-based biosensor for real-time detection of cardiotoxicity using lensfree imaging. Lab Chip 2011, 11:1801-1807.
33. Pelouch V., Dixon I.M.C., Golfman L., Beamish R.E., Dhalla N.S. Role of extracellular-matrix proteins in heart function. Mol Cell Biochem 1993, 129:101-120.
34. Mwangi J.W., Ofner C.M. Crosslinked gelatin matrices: release of a random coil macromolecular solute. Int J Pharm 2004, 278:319-327.
35. Sun Z.J., Wu L., Huang W., Zhang X.-L., Lu X.-L., Zheng Y.-F., et al. The influence of lactic on the properties of poly (glycerol-sebacate-lactic acid). Mater Sci Eng C Mater Biol Appl 2009, 29:178-182.
36. Liang S.L., Yang X.Y., Fang X.-Y., Cook W.D., Thouas G.A., Chen Q.-Z. In vitro enzymatic degradation of poly (glycerol sebacate)-based materials. Biomaterials 2011, 32:8486-8496.
37. Jacot J.G., McCulloch A.D., Omens J.H. Substrate stiffness affects the functional maturation of neonatal rat ventricular myocytes. Biophys J 2008, 95:3479-3487.
38. McDonald K.S., Wolff M.R., Moss R.L. Force-velocity and power-load curves in rat skinned cardiac myocytes. JPhysiol 1998, 511:519-531.
39. Zhang Y.Z., Venugopal J., Huang Z.M., Lim C.T., Ramakrishna S. Crosslinking of the electrospun gelatin nanofibers. Polymer 2006, 47:2911-2917.
40. Li M.Y., Guo Y., Wei Y., MacDiarmid A.G., Lelkes P.I. Electrospinning polyaniline-contained gelatin nanofibers for tissue engineering applications. Biomaterials 2006, 27:2705-2715.
41. Baji A., Mai Y.W., Wong S.-C., Abtahi M., Chen P. Electrospinning of polymer nanofibers: effects on oriented morphology, structures and tensile properties. Compos Sci Technol 2010, 70:703-718.
42. Lu J.W., Zhang Z.P., Ren X.-Z., Chen Y.-Z., Yu J., Guo Z.-X. High-elongation fiber mats by electrospinning of polyoxymethylene. Macromolecules 2008, 41:3762-3764.
43. Wu X.-F., Dzenis Y.A. Size effect in polymer nanofibers under tension. JAppl Phys 2007, 102.
44. Discher D.E., Janmey P., Wang Y.L. Tissue cells feel and respond to the stiffness of their substrate. Science 2005, 310:1139-1143.
45. Woo K.M., Chen V.J., Ma P.X. Nano-fibrous scaffolding architecture selectively enhances protein adsorption contributing to cell attachment. JBiomed Mater Res A 2003, 67A:531-537.
46. Jose M.V., Thomas V., Dean D.R., Nyairo E. Fabrication and characterization of aligned nanofibrous PLGA/collagen blends as bone tissue scaffolds. Polymer 2009, 50:3778-3785.
47. Lee J., Tae G., Kim Y.H., Park I.S., Kim S.-H., Kim S.H. The effect of gelatin incorporation into electrospun poly(l-lactide-co-epsilon-caprolactone) fibers on mechanical properties and cytocompatibility. Biomaterials 2008, 29:1872-1879.
48. Kwon I.K., Matsuda T. Co-electrospun nanofiber fabrics of poly(l-lactide-co-epsilon-caprolactone) with type I collagen or heparin. Biomacromolecules 2005, 6:2096-2105.
49. Lijnen P., Petrov V. Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes. JMol Cell Cardiol 1999, 31:949-970.
50. Poobalarahi F., Baicu C.F., Bradshaw A.D. Cardiac myofibroblasts differentiated in 3D culture exhibit distinct changes in collagen I production, processing, and matrix deposition. Am J Physiol Heart Circ Physiol 2006, 291:H2924-H2932.
51. Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. JPathol 2003, 200:500-503.
52. Eguchi S., Dempsey P.J., Frank G.D., Motley E.D., Inagami T. Activation of MAPKs by angiotensin II in vascular smooth muscle cells - metalloprotease-dependent EGFreceptor activation is required for activation of ERK and p38 MAPK but not for JNK. JBiol Chem 2001, 276:7957-7962.
53. Schorb W., Booz G.W., Dostal D.E., Conrad K.M., Chang K.C., Baker K.M. Angiotensin-ii is mitogenic in neonatal rat cardiac fibroblasts. Circ Res 1993, 72:1245-1254.
54. Wang J., Seth A., McCulloch C.A.G. Force regulates smooth muscle actinincardiac fibroblasts. Am J Physiol Heart Circ Physiol 2000, 279:H2776-H2785.
55. Wang J., Chen H., Seth A., McCulloch C.A. Mechanical force regulation of myofibroblast differentiation in cardiac fibroblasts. Am J Physiol Heart Circ Physiol 2003, 285:H1871-H1881.
56. Castella L.F., Buscemi L., Godbout C., Meister J.-J., Hinz B. Anew lock-step mechanism of matrix remodelling based on subcellular contractile events. JCell Sci 2010, 123:1751-1760.
57. Boateng S.Y., Hartman T.J., Ahluwalia N., Vidula H., Desai T.A., Russell B. Inhibition of fibroblast proliferation in cardiac myocyte cultures by surface microtopography. Am J Physiol Cell Physiol 2003, 285:C171-C182.
58. Grinnell F., Ho C.H., Tamariz E., Lee D.J., Skuta G. Dendritic fibroblasts in three-dimensional collagen matrices. Mol Biol Cell 2003, 14:384-395.
59. Nikkhah M., Eshak N., Zorlutuna P., Annabi N., Castello M., Kim K., et al. Directed endothelial cell morphogenesis in micropatterned gelatin methacrylate hydrogels. Biomaterials 2012, 33:9009-9018.
60. Parrag I.C., Zandstra P.W., Woodhouse K.A. Fiber alignment and coculture with fibroblasts improves the differentiated phenotype of murine embryonic stem cell-derived cardiomyocytes for cardiac tissue engineering. Biotechnol Bioeng 2012, 109:813-822.
61. Wu K.H., Mo X.M., Liu Y.L., Zhang Y.S., Han Z.C. Stem cells for tissue engineering of myocardial constructs. Ageing Res Rev 2007, 6:289-301.
62. Schulz R., Heusch G. Connexin 43 and ischemic preconditioning. Cardiovasc Res 2004, 62:335-344.